20/20 Biolabs updates investors on OneTest filing
The company released an investor presentation navigating revenue projections and expected FDA authorization timelines for its OneTest product.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day